Unlike regular chemotherapy, rituxan does not cause low blood counts or hair loss.
和常规化疗不同的是,美罗华不导致血细胞减少或脱发。
"We like Rituxan, and we think those trials are going to be successful," Flynn said.
福林说,我们喜欢Rituxan,我们认为试验将会成功。
Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.
Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。
应用推荐